135
Participants
Start Date
December 1, 2023
Primary Completion Date
June 30, 2024
Study Completion Date
December 31, 2025
Empagliflozin
Empagliflozin 10 mg p.o. once daily (available to control over \~25mg)
Dulaglutide
Dulaglutide 0.75mg s.c. once a week (available to control over \~1.5mg)
Empagliflozin and Dulaglutide
Empagliflozin 10 mg p.o. once daily with Dulaglutide 0.75mg s.c. once weekly
Seoul National University Bundang Hospital
OTHER